Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Recruiting · NCT06957431 · Registry updated 2026-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Recruiting | Phase 1 | 2026-06-03 | NCT06957431 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Exelixis | 77 |
| Washington University School of Medicine | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Washington University School of Medicine | St Louis | United States | 895 |